Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions - PubMed (original) (raw)
Comparative Study
Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions
P H Tu et al. Proc Natl Acad Sci U S A. 1996.
Abstract
Mutations in the human Cu,Zn superoxide dismutase gene (SOD1) are found in 20% of kindreds with familial amyotrophic lateral sclerosis. Transgenic mice (line G1H) expressing a human SOD1 containing a mutation of Gly-93 --> Ala (G93A) develop a motor neuron disease similar to familial amyotrophic lateral sclerosis, but transgenic mice (line N1029) expressing a wild-type human SOD1 transgene do not. Because neurofilament (NF)-rich inclusions in spinal motor neurons are characteristic of amyotrophic lateral sclerosis, we asked whether mutant G1H and/or N1029 mice develop similar NF lesions. NF inclusions (i.e., spheroids, Lewy body-like inclusions) were first detected in spinal cord motor neurons of the G1H mice at 82 days of age about the time these mice first showed clinical evidence of disease. Other neuronal intermediate filament proteins (alpha-internexin, peripherin) also accumulated in these spheroids. The onset of accumulations of ubiquitin immunoreactivity in the G1H mice paralleled the emergence of vacuoles and NF-rich spheroids in neurons, but they did not colocalize exclusively with spheroids. In contrast, NF inclusions were not seen in the N1029 mice until they were 132 days old, and ubiquitin immunoreactivity was not increased in the N1029 mice even at 199 days of age. Astrocytosis in spinal cord was associated with a marked increase in glial fibrillary acidic protein immunoreactivity in the G1H mice, but not in the N1029 mice. Finally, comparative studies revealed a striking similarity between the cytoskeletal pathology in the G1H transgenic mice and in patients with amyotrophic lateral sclerosis. These findings link a specific SOD1 mutation with alterations in the neuronal cytoskeleton of patients with amyotrophic lateral sclerosis. Thus, neuronal cytoskeletal abnormalities may be implicated in the pathogenesis of human familial amyotrophic lateral sclerosis.
Similar articles
- Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.
Zhang B, Tu P, Abtahian F, Trojanowski JQ, Lee VM. Zhang B, et al. J Cell Biol. 1997 Dec 1;139(5):1307-15. doi: 10.1083/jcb.139.5.1307. J Cell Biol. 1997. PMID: 9382875 Free PMC article. - Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, Verspaget HW, London J, Holstege JC. Jaarsma D, et al. Neurobiol Dis. 2000 Dec;7(6 Pt B):623-43. doi: 10.1006/nbdi.2000.0299. Neurobiol Dis. 2000. PMID: 11114261 - Characterization and changes in neurotrophin receptor p75-Expressing motor neurons in SOD1(G93A) G1H mice [corrected].
Smith KS, Rush RA, Rogers ML. Smith KS, et al. J Comp Neurol. 2015 Aug 1;523(11):1664-82. doi: 10.1002/cne.23763. Epub 2015 Apr 30. J Comp Neurol. 2015. PMID: 25711805 - Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH, Gurney ME, Julien JP, Lee VM, Trojanowski JQ. Tu PH, et al. Lab Invest. 1997 Apr;76(4):441-56. Lab Invest. 1997. PMID: 9111507 Review. - Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?
Julien JP, Beaulieu JM. Julien JP, et al. J Neurol Sci. 2000 Nov 1;180(1-2):7-14. doi: 10.1016/s0022-510x(00)00422-6. J Neurol Sci. 2000. PMID: 11090858 Review.
Cited by
- SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis.
Park JH, Elpers C, Reunert J, McCormick ML, Mohr J, Biskup S, Schwartz O, Rust S, Grüneberg M, Seelhöfer A, Schara U, Boltshauser E, Spitz DR, Marquardt T. Park JH, et al. Brain. 2019 Aug 1;142(8):2230-2237. doi: 10.1093/brain/awz182. Brain. 2019. PMID: 31332433 Free PMC article. - Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.
Johnston JA, Dalton MJ, Gurney ME, Kopito RR. Johnston JA, et al. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12571-6. doi: 10.1073/pnas.220417997. Proc Natl Acad Sci U S A. 2000. PMID: 11050163 Free PMC article. - Programmed cell death in amyotrophic lateral sclerosis.
Guégan C, Przedborski S. Guégan C, et al. J Clin Invest. 2003 Jan;111(2):153-61. doi: 10.1172/JCI17610. J Clin Invest. 2003. PMID: 12531867 Free PMC article. Review. No abstract available. - Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model.
Woo TG, Yoon MH, Kang SM, Park S, Cho JH, Hwang YJ, Ahn J, Jang H, Shin YJ, Jung EM, Ha NC, Kim BH, Kwon Y, Park BJ. Woo TG, et al. Commun Biol. 2021 Dec 15;4(1):1397. doi: 10.1038/s42003-021-02862-z. Commun Biol. 2021. PMID: 34912047 Free PMC article. - Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice.
Ozdinler PH, Benn S, Yamamoto TH, Güzel M, Brown RH Jr, Macklis JD. Ozdinler PH, et al. J Neurosci. 2011 Mar 16;31(11):4166-77. doi: 10.1523/JNEUROSCI.4184-10.2011. J Neurosci. 2011. PMID: 21411657 Free PMC article.
References
- Neurol Clin. 1985 Aug;3(3):473-93 - PubMed
- Ann Neurol. 1996 Jan;39(1):128-31 - PubMed
- Proc Natl Acad Sci U S A. 1988 Apr;85(8):2854-8 - PubMed
- J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):778-84 - PubMed
- Cell. 1993 Apr 9;73(1):35-46 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous